Dr. Hosein is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1475 NW 12th Ave
Miami, FL 33136Phone+1 305-243-3462Fax+1 305-243-4975- Is this information wrong?
Summary
- I am board certified by the American Board of Internal Medicine in Internal Medicine, Hematology and Medical Oncology. I obtained my medical degree from the University of the West Indies in Trinidad and Tobago. I did my residency in Internal Medicine and fellowship in Hematology/Oncology at the University of Miami/Jackson Memorial Hospital in Miami, Fla. I was formerly a faculty member at the University of Miami/Sylvester Comprehensive Cancer Center prior to coming to the University of Kentucky. My office is located at the Markey Cancer Center where I am a specialist in gastrointestinal cancers and sarcomas. I have conducted and participated in multiple phase I, II and III clinical trials in hematological cancers as well as gastrointestinal cancers.
My main research interest is in pancreatic cancer where I am studying new treatments for patients who are not surgical candidates. I am also conducting research in hepatocellular cancer (primary liver cancer) and gastroesophageal cancers.
Education & Training
University of Miami/Jackson Health SystemFellowship, Hematology and Medical Oncology, 2007 - 2010- University of Miami/Jackson Health SystemResidency, Internal Medicine, 2004 - 2007
University of the West Indies Faculty of MedicineClass of 2001
Certifications & Licensure
FL State Medical License 2010 - 2026
KY State Medical License 2014 - 2017- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- A Study of Combination of Gemcitabine, Oxaliplatin (GEMOX)-Sorafenib in Patients With Advanced Biliary Tract Cancer Start of enrollment: 2009 Aug 01
- Phase II Trial of SOM230 in Patients With Unresectable Hepatocellular Carcinoma Start of enrollment: 2012 Jul 01
- Immunotherapy Study in Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer Start of enrollment: 2013 May 01
- Join now to see all
Publications & Presentations
PubMed
- Improving patient stratification and selection for curative-intent treatment in localized pancreatic cancer.Haleh Amirian, Erin M Dickey, Mary P Martos, Edmond W Box, Nipun B Merchant, Peter J Hosein, Caitlin A Hester, Jashodeep Datta> ;Hepatobiliary Surgery and Nutrition. 2024 Apr 3
- 1 citationsDetection and therapeutic implications of homologous recombination repair deficiency in pancreatic cancer: a narrative review.Heng Tan, Peter J Hosein> ;Journal of Gastrointestinal Oncology. 2023 Oct 31
- Smoking induces WEE1 expression to promote docetaxel resistance in esophageal adenocarcinoma.Md Obaidul Islam, Krishnapriya Thangaretnam, Heng Lu, Dunfa Peng, Mohammed Soutto, Wael El-Rifai, Silvia Giordano, Yuguang Ban, Xi Chen, Daniel Bilbao, Alejandro V Vil...> ;Molecular Therapy Oncolytics. 2023 Sep 21
- Join now to see all
Press Mentions
‘He Took My Call and Saved My Life.’ How Two Men with Pancreatic Cancer Beat the OddsMay 13th, 2022
Earlier Nab-Paclitaxel/Gemcitabine Explored in Pancreatic CancerMay 17th, 2016- Dr. Peter Hosein Appointed to Pancreatic Cancer Action Network’s Scientific and Medical Advisory BoardAugust 5th, 2023
- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
Jackson Health SystemMiami, Florida
University of Miami HospitalMiami, Florida
Miami Veterans Affairs Healthcare SystemMiami, Florida
UMHC-Sylvester Comprehensive Cancer CenterMiami, Florida
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
